Aquestive Therapeutics (AQST) Current Leases (2020 - 2026)
Aquestive Therapeutics (AQST) recorded quarterly Current Leases of $662000.0 in Q1 2026, up 4.91% quarter-over-quarter from $631000.0 in Q4 2025, and up 22.59% on a YoY basis from $540000.0 in Q1 2025.
Aquestive Therapeutics (AQST) Current Leases (2020 - 2026) Analysis & Trends
Aquestive Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $662000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 22.59% year-over-year to $662000.0; the TTM figure through Mar 2026 stood at $662000.0 (up 22.59% YoY), while the FY2025 annual figure was $631000.0, up 23.73% from the prior year.
- Current Leases was $662000.0 for Q1 2026 at Aquestive Therapeutics, up from $631000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $926000.0 in Q1 2022 to a low of $255000.0 in Q4 2022.
- Historically, Current Leases has averaged $543352.9 across 5 years, with a median of $510000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Current Leases tumbled 71.64% in 2022, then surged 52.94% in 2023.
- A 5-year view of Current Leases shows it stood at $255000.0 in 2022, then jumped by 52.94% to $390000.0 in 2023, then jumped by 30.77% to $510000.0 in 2024, then advanced by 23.73% to $631000.0 in 2025, then climbed by 4.91% to $662000.0 in 2026.
- The last three Current Leases figures came in at $662000.0 (Q1 2026), $631000.0 (Q4 2025), and $601000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 23.81 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 7.58 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 5.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Aquestive Therapeutics | 488.60 Mn | 377.87 Mn | 10.98 Mn | 662,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 662,000.00 |
| Dec 31, 2025 | 631,000.00 |
| Sep 30, 2025 | 601,000.00 |
| Jun 30, 2025 | 570,000.00 |
| Mar 31, 2025 | 540,000.00 |
| Dec 31, 2024 | 510,000.00 |
| Sep 30, 2024 | 482,000.00 |
| Jun 30, 2024 | 455,000.00 |
| Mar 31, 2024 | 414,000.00 |
| Dec 31, 2023 | 390,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Jun 30, 2023 | 347,000.00 |
| Mar 31, 2023 | 328,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 846,000.00 |
| Jun 30, 2022 | 913,000.00 |
| Mar 31, 2022 | 926,000.00 |
| Dec 31, 2021 | 899,000.00 |
| Sep 30, 2021 | 860,000.00 |
| Jun 30, 2021 | 823,000.00 |